Atea Pharmaceuticals Inc (AVIR)
Healthcare
Biotechnology
4.70 $
-0.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Atea Pharmaceuticals Inc (AVIR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.0% of the shares are freely tradable; institutional investors hold 80.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
80.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
13.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
75.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
80Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.93 | 11,950,772 | +23.5 | 03/31/2026 |
| BlackRock Inc | 10.54 | 8,435,437 | -0.7 | 03/31/2026 |
| BML Capital Management LLC | 8.82 | 7,058,657 | -5.8 | 03/31/2026 |
| TANG CAPITAL MANAGEMENT LLC | 6.02 | 4,814,700 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.06 | 3,246,124 | +0.0 | 03/31/2026 |
| Bain Capital Life Sciences Investors, LLC | 2.95 | 2,360,638 | -5.0 | 03/31/2026 |
| Two Sigma Investments LLC | 2.33 | 1,864,164 | +150.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 8.18 | 6,543,395 | +0.1 | 05/31/2026 |
| Fidelity Growth Company Fund | 3.88 | 3,102,958 | +0.2 | 05/31/2026 |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.54 | 2,032,268 | -14.2 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.